+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Fusion Testing Market by Technology (Fluorescence In Situ Hybridization, Immunohistochemistry, Next Generation Sequencing), Sample Type (Blood, Tissue), Application, End User - Global Forecast 2025-2030- Product Image
Gene Fusion Testing Market by Technology (Fluorescence In Situ Hybridization, Immunohistochemistry, Next Generation Sequencing), Sample Type (Blood, Tissue), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Gene Fusion Testing Market by Technology (Fluorescence In Situ Hybridization, Immunohistochemistry, Next Generation Sequencing), Sample Type (Blood, Tissue), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924686
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The gene fusion testing market is rapidly evolving, driven by ongoing advancements in molecular diagnostics and increasing relevance of fusion detection in clinical decision-making. This report delivers clear, actionable insights for senior leaders evaluating growth opportunities, investment priorities, and operational strategies across global healthcare, research, and diagnostics sectors.

Market Snapshot: Gene Fusion Testing Market Size & Growth

The Gene Fusion Testing Market grew from USD 480.95 million in 2024 to USD 541.32 million in 2025. It is expected to continue growing at a CAGR of 12.45%, reaching USD 972.55 million by 2030. This expansion reflects the increasing clinical importance of gene fusion analysis in oncology, hematology, and rare disease management, as well as investment in advanced sequencing and analytical platforms among laboratory and healthcare stakeholders.

Scope & Segmentation: Comprehensive Analysis Across Regions, Technologies, and Applications

This report provides a detailed analysis across a robust set of industry segments and geographies:

  • Technology: Fluorescence In Situ Hybridization, Immunohistochemistry, Next Generation Sequencing (including Targeted Next Generation Sequencing, Transcriptome Sequencing, and Whole Genome Sequencing), and Reverse Transcription Polymerase Chain Reaction.
  • Sample Type: Blood (Plasma, Serum) and Tissue (Formalin Fixed Paraffin Embedded, Fresh Frozen Tissue).
  • Application: Hematology (including Leukemia and Lymphoma), Oncology (Breast, Colorectal, Lung, and Prostate Cancer), and Rare Diseases (Developmental Disorders, Neuromuscular Disorders).
  • End User: Diagnostic Laboratories (Hospital Based and Independent), Hospitals (Inpatient Facilities, Outpatient Clinics), Pharmaceutical Companies (Biotechnology Companies, Pharma Giants), and Research Institutions (Academic Centers, Private Research Laboratories).
  • Region: Americas (with coverage of United States states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, multiple EMENA countries), and Asia-Pacific (China, India, Japan, Australia, and more).
  • Key Companies: Thermo Fisher Scientific Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., NanoString Technologies, Inc., BGI Genomics Co., Ltd., Foundation Medicine, Inc., and Archer DX, Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Technological convergence is shaping the future of gene fusion testing, with next generation sequencing, transcriptomic profiling, and whole genome approaches expanding detection capabilities.
  • Clinical integration is accelerating, as multidisciplinary teams leverage fusion data to inform therapy selection in oncology, risk stratification in hematology, and investigation of rare diseases.
  • Regulatory frameworks are adapting to the rise of multiplexed assays and digital pathology tools, streamlining submissions and incentivizing novel diagnostics.
  • Competitive dynamics continue to intensify; established players and emerging firms compete through innovation in assay sensitivity, automation, and informatics.
  • Global market access varies: mature infrastructure and reimbursement policies drive early adoption in some regions, while others address cost and logistical barriers through partnerships and technology transfer.
  • Collaboration between academic institutions, commercial developers, and public agencies supports the harmonization of protocols and cross-border clinical trials.

Assessing Tariff Impact: Navigating 2025 U.S. Policy Changes

Impending tariff revisions in the United States are expected to influence supply chain dynamics, altering import costs for sequencing reagents, instrumentation components, and critical consumables. Laboratories and reagent manufacturers may need to reevaluate domestic sourcing, negotiate alternative supplier agreements, and invest in inventory management to ensure uninterrupted assay availability. Industry advocacy for exemptions and emphasis on local manufacturing are core components of strategic risk mitigation in response to these changes.

Market Research Methodology & Data Sources

This analysis applies a structured research approach, integrating primary interviews with laboratory leaders, clinicians, and industry executives alongside global surveys. Secondary data from peer-reviewed publications, regulatory databases, and proprietary company information were triangulated for accuracy. Statistical and thematic analyses, together with expert validation, underpin the report’s comprehensive market perspective.

Why This Report Matters: Actionable Intelligence for Senior Leaders

  • Supports evidence-based strategic decisions by equipping executives with a nuanced understanding of market and technology trajectories in gene fusion testing.
  • Enables effective risk management and investment planning amid regulatory shifts, supply chain disruptions, and regional reimbursement challenges.
  • Empowers cross-functional teams to prioritize innovation partnerships and pursue scalable adoption of advanced diagnostics.

Conclusion

The gene fusion testing market stands at a pivotal point, shaped by technological advances, adaptive regulation, and growing clinical demand. This report provides the clarity senior leaders need to make informed, forward-looking investments in gene fusion diagnostics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of multiplex next-generation sequencing assays for simultaneous gene fusion detection in oncology patients
5.2. Integration of liquid biopsy platforms for noninvasive detection of gene fusions in cancer screening programs
5.3. Expansion of targeted therapies driving demand for precise gene fusion profiling in personalized medicine
5.4. Development of AI-enabled bioinformatics pipelines to improve gene fusion identification accuracy in clinical diagnostics
5.5. Growth of lab-developed tests offering rapid gene fusion analysis for point-of-care oncology decision support
5.6. Rising collaborations between diagnostic companies and pharmaceutical firms to co-develop fusion-driven therapeutic biomarkers
5.7. Regulatory approvals for novel gene fusion detection kits accelerating market entry across emerging geographies
5.8. Increasing utilization of RNA-based multiplex PCR assays for comprehensive detection of rare fusion transcripts in solid tumors
5.9. Emergence of automated sample-to-report platforms reducing turnaround time for gene fusion analysis in clinical labs
5.10. Investment trends fueling expansion of decentralized testing networks for gene fusion assays in community hospitals
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Fusion Testing Market, by Technology
8.1. Introduction
8.2. Fluorescence In Situ Hybridization
8.3. Immunohistochemistry
8.4. Next Generation Sequencing
8.4.1. Targeted Next Generation Sequencing
8.4.2. Transcriptome Sequencing
8.4.3. Whole Genome Sequencing
8.5. Reverse Transcription Polymerase Chain Reaction
9. Gene Fusion Testing Market, by Sample Type
9.1. Introduction
9.2. Blood
9.2.1. Plasma
9.2.2. Serum
9.3. Tissue
9.3.1. Formalin Fixed Paraffin Embedded
9.3.2. Fresh Frozen Tissue
10. Gene Fusion Testing Market, by Application
10.1. Introduction
10.2. Hematology
10.2.1. Leukemia
10.2.2. Lymphoma
10.3. Oncology
10.3.1. Breast Cancer
10.3.2. Colorectal Cancer
10.3.3. Lung Cancer
10.3.4. Prostate Cancer
10.4. Rare Diseases
10.4.1. Developmental Disorders
10.4.2. Neuromuscular Disorders
11. Gene Fusion Testing Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.2.1. Hospital Based Laboratories
11.2.2. Independent Laboratories
11.3. Hospitals
11.3.1. Inpatient Facilities
11.3.2. Outpatient Clinics
11.4. Pharmaceutical Companies
11.4.1. Biotechnology Companies
11.4.2. Pharma Giants
11.5. Research Institutions
11.5.1. Academic Centers
11.5.2. Private Research Laboratories
12. Americas Gene Fusion Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gene Fusion Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gene Fusion Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Illumina, Inc.
15.3.3. F. Hoffmann-La Roche Ltd
15.3.4. Agilent Technologies, Inc.
15.3.5. QIAGEN N.V.
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. NanoString Technologies, Inc.
15.3.8. BGI Genomics Co., Ltd.
15.3.9. Foundation Medicine, Inc.
15.3.10. Archer DX, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GENE FUSION TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENE FUSION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE FUSION TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE FUSION TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GENE FUSION TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GENE FUSION TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. GENE FUSION TESTING MARKET: RESEARCHAI
FIGURE 24. GENE FUSION TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. GENE FUSION TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. GENE FUSION TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENE FUSION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE FUSION TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENE FUSION TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENE FUSION TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENE FUSION TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENE FUSION TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENE FUSION TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENE FUSION TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENE FUSION TESTING MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FORMALIN FIXED PARAFFIN EMBEDDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FORMALIN FIXED PARAFFIN EMBEDDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENE FUSION TESTING MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENE FUSION TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENE FUSION TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DEVELOPMENTAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DEVELOPMENTAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENE FUSION TESTING MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENE FUSION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INPATIENT FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GENE FUSION TESTING MARKET SIZE, BY INPATIENT FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GENE FUSION TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GENE FUSION TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GENE FUSION TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMA GIANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMA GIANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ACADEMIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GENE FUSION TESTING MARKET SIZE, BY ACADEMIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PRIVATE RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GENE FUSION TESTING MARKET SIZE, BY PRIVATE RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS GENE FUSION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES GENE FUSION TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 169. CANADA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. CANADA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. CANADA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 172. CANADA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 173. CANADA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. CANADA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 176. CANADA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 177. CANADA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 178. CANADA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 179. CANADA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 182. CANADA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 183. CANADA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 184. CANADA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 185. CANADA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 186. CANADA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 187. CANADA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. CANADA GENE FUSION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. CANADA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 190. CANADA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 191. CANADA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. CANADA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. CANADA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 194. CANADA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 195. CANADA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 196. CANADA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. MEXICO GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. MEXICO GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 200. MEXICO GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 201. MEXICO GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 204. MEXICO GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 205. MEXICO GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 206. MEXICO GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 207. MEXICO GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 210. MEXICO GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 211. MEXICO GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 212. MEXICO GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 213. MEXICO GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 214. MEXICO GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 215. MEXICO GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. MEXICO GENE FUSION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. MEXICO GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 218. MEXICO GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 219. MEXICO GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. MEXICO GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 222. MEXICO GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 223. MEXICO GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL GENE FUSION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA GENE FUSION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM GENE FUSION TESTING MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Gene Fusion Testing market report include:
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • NanoString Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Foundation Medicine, Inc.
  • Archer DX, Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 541.32 Million
Forecasted Market Value ( USD ) by 2030 $ 972.55 Million
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gene Fusion Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Gene Fusion Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Gene Fusion Testing Market - A Global and Regional Analysis: Focus on Category, Technology, Indication, End User, and Region - Analysis and Forecast, 2025-2035 - Product Image

Gene Fusion Testing Market - A Global and Regional Analysis: Focus on Category, Technology, Indication, End User, and Region - Analysis and Forecast, 2025-2035

  • Report
  • 130 Pages
  • Global
From
Gene Panel Market Size, Share & Trends Analysis Report By Product & Services (Test Kits, Testing Services), By Technique (Amplicon Based), By Design, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Gene Panel Market Size, Share & Trends Analysis Report By Product & Services (Test Kits, Testing Services), By Technique (Amplicon Based), By Design, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Lentiviral Vector Contract Development and Manufacturing Organizations - Global Strategic Business Report - Product Image

Lentiviral Vector Contract Development and Manufacturing Organizations - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Deafness Susceptibility Gene Detection Kit Market by Technology, Application, End User, Mutation Type, Distribution Channel - Global Forecast to 2030 - Product Image

Deafness Susceptibility Gene Detection Kit Market by Technology, Application, End User, Mutation Type, Distribution Channel - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.